HALOTHANE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for halothane and what is the scope of patent protection?
Halothane
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst, BH, Halocarbon, and Hospira, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for halothane.
Summary for HALOTHANE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 10 |
Patent Applications: | 6,969 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HALOTHANE at DailyMed |
Recent Clinical Trials for HALOTHANE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital Olomouc | Phase 2 |
The Institute of Molecular and Translational Medicine, Czech Republic | Phase 2 |
Marian Hajduch, M.D., Ph.D. | Phase 2 |
Medical Subject Heading (MeSH) Categories for HALOTHANE
US Patents and Regulatory Information for HALOTHANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | HALOTHANE | halothane | LIQUID;INHALATION | 083254-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bh | HALOTHANE | halothane | LIQUID;INHALATION | 084977-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Halocarbon | HALOTHANE | halothane | LIQUID;INHALATION | 080810-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | FLUOTHANE | halothane | LIQUID;INHALATION | 011338-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |